OraSure Director Nancy Gagliano Selected to Serve as Interim Chief Executive Officer; Brings Extensive Diagnostics and Healthcare Leadership Experience to Role
March 22, 2022 16:05 ET
|
OraSure Technologies, Inc.
Board Continues Search for Permanent CEO Evaluation of Strategic Alternatives Ongoing BETHLEHEM, Pa., March 22, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader...
OraSure Technologies Reports 4Q21 Revenue of $63.6 Million; InteliSwab® Production Scales Up
February 23, 2022 16:05 ET
|
OraSure Technologies, Inc.
Total 2021 revenue of $233.7 million, up 36% year-over year InteliSwab® receives emergency use authorization expansion and demonstrates accurate detection of Omicron variant InteliSwab® revenue of...
OraSure Technologies, Inc. 2021 Fourth Quarter Earnings Conference Call Wednesday, February 23, 2022, 5:00 p.m. ET
February 16, 2022 16:05 ET
|
OraSure Technologies, Inc.
BETHLEHEM, Pa., Feb. 16, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2021 fourth quarter financial results and...
InteliSwab® COVID-19 Rapid Tests Receive U.S. FDA Authorization for Pediatric Use and Company Launches New InteliSwab® Connect Reporting App
January 31, 2022 07:05 ET
|
OraSure Technologies, Inc.
Data Demonstrates InteliSwab® is Accurate, Easy to Use, and Well Accepted by Children BETHLEHEM, Pa., Jan. 31, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader...
OraSure Technologies, Inc. Expands HIV Oral Swab In-home Test into Europe
January 25, 2022 07:05 ET
|
OraSure Technologies, Inc.
BETHLEHEM, Pa., Jan. 25, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies,...
InteliSwab® COVID-19 Rapid Tests Detect Omicron at Same Level as Other Variants
January 13, 2022 16:05 ET
|
OraSure Technologies, Inc.
BETHLEHEM, Pa., Jan. 13, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies,...
OraSure Technologies Announces Actions to Enhance Stockholder Value
January 05, 2022 07:05 ET
|
OraSure Technologies, Inc.
Provides Preliminary 4Q21 Financial OutlookCommences Review of Strategic AlternativesAnnounces Transition of CEO and Organizational ChangesBETHLEHEM, Pa., Jan. 05, 2022 (GLOBE NEWSWIRE) -- OraSure...
OraSure Technologies Announces 2022 Annual Meeting Date
December 14, 2021 07:05 ET
|
OraSure Technologies, Inc.
BETHLEHEM, Pa., Dec. 14, 2021 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) today announced that its 2022 Annual Meeting of Stockholders is scheduled to be held at 10:00 a.m. EDT...
OraSure Technologies Remains Committed to the Global Fight Against HIV 40 Years After the Discovery of the HIV Virus
November 30, 2021 07:05 ET
|
OraSure Technologies, Inc.
BETHLEHEM, Pa., Nov. 30, 2021 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in the fight against HIV, today announced its plans for World AIDS Day. Commemorated...
OraSure Technologies to Present at Upcoming Investor Conferences
November 19, 2021 07:05 ET
|
OraSure Technologies, Inc.
BETHLEHEM, Pa., Nov. 19, 2021 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests, specimen collection devices, microbiome laboratory and...